Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.

van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW.

Hum Reprod. 2011 Dec;26(12):3456-65. doi: 10.1093/humrep/der322. Epub 2011 Oct 26.

2.

Melanoma risk after ovarian stimulation for in vitro fertilization.

Spaan M, van den Belt-Dusebout AW, Schaapveld M, Mooij TM, Burger CW, van Leeuwen FE; OMEGA-project group..

Hum Reprod. 2015 May;30(5):1216-28. doi: 10.1093/humrep/dev023. Epub 2015 Mar 4.

PMID:
25743782
3.

Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Rizzuto I, Behrens RF, Smith LA.

Cochrane Database Syst Rev. 2013 Aug 13;(8):CD008215. doi: 10.1002/14651858.CD008215.pub2. Review.

PMID:
23943232
4.

Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.

van den Belt-Dusebout AW, Spaan M, Lambalk CB, Kortman M, Laven JS, van Santbrink EJ, van der Westerlaken LA, Cohlen BJ, Braat DD, Smeenk JM, Land JA, Goddijn M, van Golde RJ, van Rumste MM, Schats R, Józwiak K, Hauptmann M, Rookus MA, Burger CW, van Leeuwen FE.

JAMA. 2016 Jul 19;316(3):300-12. doi: 10.1001/jama.2016.9389.

PMID:
27434442
5.

Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women.

Klip H, van Leeuwen FE, Schats R, Burger CW; OMEGA Project Group..

Hum Reprod. 2003 Sep;18(9):1951-8.

PMID:
12923156
6.

Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.

Buis CC, van Leeuwen FE, Mooij TM, Burger CW; OMEGA Project Group..

Hum Reprod. 2013 Dec;28(12):3358-69. doi: 10.1093/humrep/det340. Epub 2013 Sep 5.

PMID:
24014607
7.

Breast and ovarian cancer incidence after infertility and in vitro fertilisation.

Venn A, Watson L, Lumley J, Giles G, King C, Healy D.

Lancet. 1995 Oct 14;346(8981):995-1000.

PMID:
7475593
8.

Risk of Colorectal Cancer After Ovarian Stimulation for In Vitro Fertilization.

Spaan M, van den Belt-Dusebout AW, Burger CW, van Leeuwen FE; OMEGA-project group..

Clin Gastroenterol Hepatol. 2016 May;14(5):729-37.e5. doi: 10.1016/j.cgh.2015.12.018. Epub 2015 Dec 12.

PMID:
26687912
9.

Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF.

Klip H, Burger CW, de Kraker J, van Leeuwen FE; OMEGA-project group..

Hum Reprod. 2001 Nov;16(11):2451-8.

PMID:
11679537
10.

In vitro fertilization is associated with an increased risk of borderline ovarian tumours.

Stewart LM, Holman CD, Finn JC, Preen DB, Hart R.

Gynecol Oncol. 2013 May;129(2):372-6. doi: 10.1016/j.ygyno.2013.01.027. Epub 2013 Feb 4.

PMID:
23385152
11.

Risk of cancer after use of fertility drugs with in-vitro fertilisation.

Venn A, Watson L, Bruinsma F, Giles G, Healy D.

Lancet. 1999 Nov 6;354(9190):1586-90.

PMID:
10560672
12.

Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation?

Kapiteijn K, de Bruijn CS, de Boer E, de Craen AJ, Burger CW, van Leeuwen FE, Helmerhorst FM.

Hum Reprod. 2006 Dec;21(12):3228-34. Epub 2006 Oct 5.

PMID:
17023490
13.

Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.

Bjørnholt SM, Kjaer SK, Nielsen TS, Jensen A.

Hum Reprod. 2015 Jan;30(1):222-31. doi: 10.1093/humrep/deu297. Epub 2014 Nov 5.

PMID:
25376453
14.

Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.

Sanner K, Conner P, Bergfeldt K, Dickman P, Sundfeldt K, Bergh T, Hagenfeldt K, Janson PO, Nilsson S, Persson I.

Fertil Steril. 2009 Apr;91(4):1152-8. doi: 10.1016/j.fertnstert.2008.01.073. Epub 2008 Apr 18.

PMID:
18371964
15.

In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk.

Stewart LM, Holman CD, Aboagye-Sarfo P, Finn JC, Preen DB, Hart R.

Gynecol Oncol. 2013 Feb;128(2):260-4. doi: 10.1016/j.ygyno.2012.10.023. Epub 2012 Oct 29.

PMID:
23116937
16.

Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.

Siristatidis C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, Psaltopoulou T, Skalkidou A, Petridou ET.

Hum Reprod Update. 2013 Mar-Apr;19(2):105-23. doi: 10.1093/humupd/dms051. Epub 2012 Dec 18. Review.

PMID:
23255514
17.

The possible association between IVF and breast cancer incidence.

Pappo I, Lerner-Geva L, Halevy A, Olmer L, Friedler S, Raziel A, Schachter M, Ron-El R.

Ann Surg Oncol. 2008 Apr;15(4):1048-55. doi: 10.1245/s10434-007-9800-2. Epub 2008 Jan 23.

PMID:
18214616
18.

Second neoplasms after invasive and borderline ovarian cancer.

Levi F, Randimbison L, Blanc-Moya R, La Vecchia C.

Eur J Cancer Prev. 2009 Jun;18(3):216-9. doi: 10.1097/CEJ.0b013e3283240474.

PMID:
19491608
19.

Ovarian cancer risk after the use of ovulation-stimulating drugs.

Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL.

Obstet Gynecol. 2004 Jun;103(6):1194-203.

PMID:
15172852
20.

Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients.

Venn A, Jones P, Quinn M, Healy D.

Gynecol Oncol. 2001 Jul;82(1):64-8.

PMID:
11426963

Supplemental Content

Support Center